CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-16 | Sheena Jonathan Director | Sale 10b5-1 | −425 | $164.64 | $70K | 37,981 |
| 2025-06-16 | Sheena Jonathan Director | Sale 10b5-1 | −699 | $165.41 | $116K | 37,282 |
| 2025-06-13 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −5,000 | $165.85 | $829K | 30,000 |
| 2025-06-10 | Marcus Gail Boxer Director | Sale 10b5-1 | −3,400 | $164.33 | $559K | 6,304 |
| 2025-06-10 | Marcus Gail Boxer Director | Sale 10b5-1 | −600 | $165.05 | $99K | 5,704 |
| 2025-06-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,290 | $156.30 | $202K | 134,915 |
| 2025-06-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,145 | $157.23 | $180K | 133,770 |
| 2025-06-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −465 | $158.37 | $74K | 133,305 |
| 2025-06-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −100 | $159.12 | $16K | 133,205 |
| 2025-06-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,512 | $156.07 | $236K | 183,670 |
| 2025-06-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −3,123 | $157.03 | $490K | 180,547 |
| 2025-06-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,476 | $158.33 | $234K | 179,071 |
| 2025-05-28 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −10,000 | $161.00 | $1.6M | 35,000 |
| 2025-05-27 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,649 | $156.85 | $259K | 128,556 |
| 2025-05-27 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −1,438 | $156.85 | $226K | 153,799 |
| 2025-05-20 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −10,000 | $153.90 | $1.5M | 45,000 |
| 2025-05-16 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −10,000 | $152.60 | $1.5M | 64,000 |
| 2025-05-16 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −9,000 | $153.10 | $1.4M | 55,000 |
| 2025-05-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −10,000 | $150.20 | $1.5M | 74,000 |
| 2025-05-12 | Sheena Jonathan Director | Sale 10b5-1 | −403 | $156.90 | $63K | 39,879 |
Page 45 of 55 · 1,093 trades